Crescita Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	15	9	11	10	13	14
Market Cap Growth	36.92%	-19.24%	13.15%	-27.14%	-1.60%	-5.64%
Enterprise Value	8.5	0.36	2.16	1.21	6.39	4.81
Last Close Price	0.79	0.48	0.58	0.49	0.66	0.65
PE Ratio	-	-	-	-	16.50	-
PS Ratio	0.63	0.42	0.57	0.56	0.57	0.81
PB Ratio	1.02	0.57	0.70	0.52	0.64	0.66
P/TBV Ratio	1.03	0.58	0.71	0.53	0.66	0.66
P/FCF Ratio	22.01	12.07	7.18	5.03	-	-
P/OCF Ratio	8.51	8.33	4.06	4.71	-	-
EV/Sales Ratio	0.37	0.02	0.11	0.07	0.27	0.29
EV/EBITDA Ratio	24.00	0.75	-	-	3.20	7.29
EV/EBIT Ratio	-	-	-	-	12.08	-
EV/FCF Ratio	12.72	0.48	1.40	0.62	-	-
Debt / Equity Ratio	0.14	0	0.02	0.04	0.06	0.12
Debt / EBITDA Ratio	-	0.70	-	-	0.81	4.35
Debt / FCF Ratio	1.67	0.45	0.54	0.65	-	-
Net Debt / Equity Ratio	-0.43	-0.53	-0.53	-0.43	-0.31	-0.41
Net Debt / EBITDA Ratio	151.44	-17.21	4.56	18.07	-3.31	-12.82
Net Debt / FCF Ratio	-4.16	-11.14	-5.48	-4.18	5.30	4.36
Asset Turnover	1.09	1.00	0.84	0.66	0.82	0.60
Inventory Turnover	2.52	2.28	2.08	1.22	2.06	1.72
Quick Ratio	1.99	2.21	1.93	2.17	2.11	2.00
Current Ratio	2.80	3.33	2.77	3.80	3.39	2.99
Return on Equity (ROE)	-4.74%	-0.59%	-15.87%	-9.95%	4.14%	-5.30%
Return on Assets (ROA)	-5.55%	-5.38%	-13.80%	-9.57%	3.93%	-2.82%
Return on Invested Capital (ROIC)	-15.02%	-15.18%	-34.78%	-19.89%	8.39%	-7.67%
Return on Capital Employed (ROCE)	-7.25%	-6.41%	-17.86%	-9.28%	2.37%	-3.24%
Earnings Yield	-	0.00%	-	-	6.06%	-
FCF Yield	4.54%	8.28%	13.92%	19.87%	-	-
Buyback Yield / Dilution	2.43%	2.61%	4.43%	3.55%	-1.18%	1.02%
Total Shareholder Return	2.43%	2.61%	4.43%	3.55%	-1.18%	1.02%